The global infectious disease diagnostics market is anticipated to grow at a considerable CAGR of 5.9% during the forecast period (2022-2028). The burden of infectious diseases on the world is overwhelming. The advent of advanced technologies such as machine learning (ML) and artificial intelligence (AI) has brought a paradigm shift in the manner in which a disease is diagnosed. Clinical microbiology laboratories have been transforming the manual processing of specimens to technology-driven automation and digitalization. Using AI to diagnose infectious diseases has many advantages.
Browse the full report description of “Infectious Disease Diagnostics Market Size, Share & Trends Analysis Report by Product & Solution (Consumables, Instruments, and Software & Services), by Technology (Immunodiagnostics, Clinical Microbiology, Polymerase Chain Reaction, Isothermal Nucleic Acid Amplification Technology, DNA Sequencing and Next-Generation Sequencing (NGS), DNA Microarray Technology, and Other Technologies) by Disease Type (Hepatitis, Human Immunodeficiency Virus (HIV), Hospital-Acquired Infections (HAIS), Human, Papillomavirus (HPV), Tuberculosis (TB), Influenza and Other Diseases) and by End-User (Hospital/Clinical Laboratories, Reference Laboratories, Academics/Research Institutes, and Others) Forecast Period (2022-2028)” at https://www.omrglobal.com/industry-reports/infectious-disease-diagnostics-market
For instance, AI can recognize signs and symptoms of infectious diseases before they’re noticeable to human senses. It can also predict disease outbreaks, helping hospitals react to prevent infections from spreading among their patients and staff. the growing implementation of AI-enabled diagnostic procedures for accurate and speedy diagnosis of diseases is anticipated to drive the global infectious disease diagnostic market. For instance, in October 2021, Roche has collaborated with PathAI for the development of artificial intelligence (AI) based digital pathology applications for enhanced patient care. As part of the development and distribution agreement, the partnership will focus on the development of an embedded image analysis workflow for pathologists. The new workflow will enable to the integration of PathAI image analysis algorithms into NAVIFY Digital Pathology, the cloud version of Roche’s uPath enterprise software.
Market Coverage
• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
o By Product & Solution
o By Technology
o By Disease Type
o By End-User
• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
• Competitive Landscape- including HYUNDAI Steel, Nippon Steel Corp., SAIL (Steel Authority Of India), Tata Steel, United States Steel, JSW, SMS Group GmbH, and others.
Key questions addressed by the report
• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?
Global Infectious Disease Diagnostics Market Report Segment
By Product & Solution
By Technology
By Disease Type
By End-User
Global Infectious Disease Diagnostics Market Report Segment by Region
North America
• United States
• Canada
Europe
• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe
Asia-Pacific
• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific
Rest of the World
• Latin America
• Middle East & Africa
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/infectious-disease-diagnostics-market